Skip to main content

Table 2 Low birth weight, preterm birth, miscarriage, and stillbirth by treatment group

From: Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial

Birth outcomes

Intervention arm SPAZ % (n/N)

Control arm SP % (n/N)

RR [95% CI]

Primary outcome

 Low birth weight

8.7% (39/450)

9.4% (42/448)

0.92 [0.61–1.40]

Secondary outcomes

 Preterm birth

5% (23/460)

4.3% (20 /463)

1.16 [0.64–2.08]

 Miscarriage

0.7% (3/460))

0.9% (4/463)

0.75 [0.17–3.35]

 Stillbirth

1.5% (7/460)

2.4% (11/463)

0.64 [0.25–1.64]

  1. SP Sulfadoxine-pyrimethamine, SPAZ SP + azithromycin, RR Risk ratio, CI confident interval